Sun Pharma, Lupin recall products in US market
Sun Pharma is recalling 696 bottles of Pregabalin capsules (50 mg), used for the treatment of epilepsy, anxiety, and nerve pain, in the US market.Lupin, on the other hand, is recalling 50,832 bottles of Gatifloxacin Ophthalmic Solution, an antibiotic used to treat bacterial infections of the eyes
Sun Pharma gains 4% on earnings optimism, stock scales a 5-year high
The better traction in the specialty segment and improvement in domestic business to drive the margin expansion in Q3.
Hold Sun Pharma; target of Rs 775: Emkay Global Financial
Emkay Global Financial recommended hold rating on Sun Pharma with a target price of Rs 775 in its research report dated January 10, 2022.
sun phaWhy you should continue to hold Sun Pharma stock
At the current price of 845, it offers a decent hedge with growth drivers amidst uncertain times
Sun Pharma expected to shine on domestic prospects, US sales ramp up
Anti-covid drug approval, new facility are the near term triggers SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sun Pharma mulling new manufacturing unit in AP
Drug marker discusses modalities of setting up a new plant in the State SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release relating to Sun Pharma receiving DCGI approval for Molxvir(r) (Molnupiravir) in India. SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Closure of Trading Window
This is to inform you that in compliance with the Company''s Code of Conduct for prevention of Insider Trading, the window for dealing in shares of the Company by Designated Persons of the Company (alongwith his/her immediate relatives or any person with whom he/ she shares a material financial relationship), will be closed from Saturday, 1st January, 2022 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2021. The date of the Board Meeting of the Company for declaration of the financial results for the quarter and nine months ended 31st December, 2021 will be intimated in due course. This is for your information and dissemination.
Sun Pharma vs Dr Reddy's: Which is Better?
In an extremely competitive market, two pharma companies are competing against each other to grab the top spot